Pharmaceutical giant Roche inaugurated Switzerland’s tallest building on Friday. The 205-metre-tall structure in Basel, known as Building 2, will house 3,500 workers.
The new high rise surpasses the firm’s nearby tower – Building 1 – which stands at 178 metres.
The new 50-floor high-rise office, with a total floor space of 83,000 metres, was designed by the renowned Swiss architectural firm Herzog & de Meuron; it cost CHF550 million ($561 million) to build.
The white, sleek staircase shaped towers can be seen from nearly everywhere in Basel in northwest Switzerland.
“Building 2 is another highly visible sign of Roche’s commitment to Basel – the city where Roche was founded over 125 years ago,” said Roche CEO Severin Schwan in a statementExternal link on Friday.
Tight planning regulation restrictions in many Swiss urban areas mean that there are few skyscrapers in Switzerland.
The construction of the twin towers in Basel allows Roche to bring together staff who were previously working in different locations across the city. Two thousand employees work in Building 1.
The pharma giant is continuing its investment in Basel with plans for a new CHF1.2 billion research & development centre, which is due to open in autumn 2024.
Roche is one of the biggest private employers in Switzerland with 15,000 staff based on four sites (two in Basel, and others in Zurich and Rotkreuz); it employs 100,000 people worldwide.
Popular Stories
More
Swiss Abroad
Aussie adoptee gains Swiss citizenship at 54 thanks to old envelope
Basel diocese files five claims of sexual abuse in Swiss Catholic Church
This content was published on
The diocese of Basel has received 141 reports of sexual abuse since the publication of a sweeping study on violations in the Catholic Church by the University of Zurich in 2023.
Swiss president calls for open markets and stable institutions in WEF speech
This content was published on
Swiss President Karin Keller-Sutter was among speakers at the WEF in Davos to make the case for fair competition, a day after Donald Trump became the 47th president of the United States.
Swiss film in competition at the 75th Berlinale has a shot at Golden Bear
This content was published on
The feature film La Cache by Lausanne screenwriter and director Lionel Baier has a chance of winning the Silver or Golden Bear at the 75th Berlinale, festival organisers said on Tuesday.
Swiss politician who shot at image of Jesus resigns from Liberal Green Party
This content was published on
Sanija Ameti, who caused controversy after shooting at an image of Jesus and Mary last September, has resigned from the Liberal Green Party.
Swiss campaigners gather enough signatures to submit ‘responsible business’ initiative
This content was published on
The Swiss people are set to vote again on the corporate responsibility of multinationals after campaigners collected 183,661 signatures in 14 days for their new 'responsible business' initiative.
Several Swiss municipalities and banks hit by cyberattack
This content was published on
Russian hackers attacked the websites of several Swiss municipalities and banks on Tuesday, just as the World Economic Forum (WEF), got under way in Davos.
Music strengthens brain connections in premature babies, Swiss study shows
This content was published on
In premature babies, music strengthens connections in certain areas of the brain, according to a years-long study by the University Hospitals of Geneva (HUG).
WEF gives Crystal Award to Beckham, Yamamoto and von Fürstenberg
This content was published on
The World Economic Forum in Davos handed out awards to UNICEF ambassador David Beckham, Japanese architect Riken Yamamoto and women's rights activist Diane von Fürstenberg.
Swiss CEOs betting on a strong domestic market in 2025
This content was published on
Swiss business leaders are optimistic about 2025, despite a world in crisis, says a new survey by Pricewaterhouse Coopers.
This content was published on
Economics Minister Guy Parmelin and Foreign Minister Ignazio Cassis have welcomed Chinese Vice Premier Ding Xuexiang to Bern
If you want to start a conversation about a topic raised in this article or want to report factual errors, email us at english@swissinfo.ch.
Read more
More
What’s behind the Novartis job cuts?
This content was published on
The recent decision by the Swiss drugmaker to shed 7% of its workforce is more than just a cost-cutting measure - it’s a turning point for Novartis.
You can find an overview of ongoing debates with our journalists here . Please join us!
If you want to start a conversation about a topic raised in this article or want to report factual errors, email us at english@swissinfo.ch.